Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Lack of Gut Secretory Immunoglobulin A in Memory B-Cell Dysfunction-Associated Disorders: A Possible Gut-Spleen Axis.

Carsetti R, Di Sabatino A, Rosado MM, Cascioli S, Piano Mortari E, Milito C, Grimsholm O, Aranburu A, Giorda E, Tinozzi FP, Pulvirenti F, Donato G, Morini F, Bagolan P, Corazza GR, Quinti I.

Front Immunol. 2020 Jan 8;10:2937. doi: 10.3389/fimmu.2019.02937. eCollection 2019.

2.

Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet).

Pulvirenti F, Sangerardi M, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Trizzino A, Aiuti A, Migliavacca M, Locatelli F, Bertaina A, Naviglio S, Carrabba M, De Carli M, Barbaro MGF, Gattorno M, Quinti I, Martire B.

J Clin Immunol. 2019 Dec 20. doi: 10.1007/s10875-019-00725-1. [Epub ahead of print]

PMID:
31863244
3.

The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.

Farrugia A, Grazzini G, Quinti I, Candura F, Profili S, Liumbruno GM.

Blood Transfus. 2019 Nov;17(6):449-458. doi: 10.2450/2019.0265-19. Epub 2019 Dec 11. Review.

4.

Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment.

Prezzo A, Cavaliere FM, Bilotta C, Pentimalli TM, Iacobini M, Cesini L, Foà R, Mauro FR, Quinti I.

Leuk Res. 2019 Dec;87:106233. doi: 10.1016/j.leukres.2019.106233. Epub 2019 Oct 3.

PMID:
31639635
5.

Appropriate lung management in patients with primary antibody deficiencies.

Cinetto F, Scarpa R, Pulvirenti F, Quinti I, Agostini C, Milito C.

Expert Rev Respir Med. 2019 Sep;13(9):823-838. doi: 10.1080/17476348.2019.1641085. Epub 2019 Jul 30.

PMID:
31361157
6.

The olfactory function in patients with common variable immunodeficiency.

Magliulo G, Iannella G, Ciofalo A, Angeletti D, Pulvirenti F, Quinti I.

Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Nov;136(6):429-434. doi: 10.1016/j.anorl.2018.02.003. Epub 2019 Jun 10.

PMID:
31196799
7.

The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy.

Pensieri MV, Pulvirenti F, Schiepatti A, Maimaris S, Lattanzio S, Quinti I, Klersy C, Corazza GR, Biagi F.

Scand J Gastroenterol. 2019 Feb;54(2):164-168. doi: 10.1080/00365521.2019.1568543. Epub 2019 Apr 21.

PMID:
31006294
8.

Genetic stability of Campylobacter coli in patients with primary antibody deficiencies.

Milito C, Quinti I.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1707. doi: 10.1016/j.jaip.2019.02.033. Epub 2019 Mar 27. No abstract available.

PMID:
30928482
9.

Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies.

Milito C, Pulvirenti F, Cinetto F, Lougaris V, Soresina A, Pecoraro A, Vultaggio A, Carrabba M, Lassandro G, Plebani A, Spadaro G, Matucci A, Fabio G, Dellepiane RM, Martire B, Agostini C, Abeni D, Tabolli S, Quinti I.

J Allergy Clin Immunol. 2019 Aug;144(2):584-593.e7. doi: 10.1016/j.jaci.2019.01.051. Epub 2019 Mar 22.

10.

Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Weidemann J, Berthold D, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Feb;39(2):225-227. doi: 10.1007/s10875-019-00609-4.

PMID:
30905051
11.

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.

Na IK, Buckland M, Agostini C, Edgar JDM, Friman V, Michallet M, Sánchez-Ramón S, Scheibenbogen C, Quinti I.

Eur J Haematol. 2019 Jun;102(6):447-456. doi: 10.1111/ejh.13223. Epub 2019 Mar 24.

12.

Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-Analysis.

Peshko D, Kulbachinskaya E, Korsunskiy I, Kondrikova E, Pulvirenti F, Quinti I, Blyuss O, Dunn Galvin A, Munblit D.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1929-1957.e5. doi: 10.1016/j.jaip.2019.02.013. Epub 2019 Feb 20.

PMID:
30797077
13.

The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity.

Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, Scheible R, Rusch S, Gasteiger LM, Grimbacher B, Mahlaoui N, Ehl S; ESID Registry Working Party and collaborators.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1763-1770. doi: 10.1016/j.jaip.2019.02.004. Epub 2019 Feb 15.

PMID:
30776527
14.

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.

Pulvirenti F, Cinetto F, Pecoraro A, Carrabba M, Crescenzi L, Neri R, Bonanni L, Fabio G, Agostini C, Spadaro G, Tabolli S, Farrugia A, Quinti I, Milito C.

J Clin Immunol. 2019 Feb;39(2):159-170. doi: 10.1007/s10875-019-0592-5. Epub 2019 Jan 15.

15.

Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group.

Bomken S, van der Werff Ten Bosch J, Attarbaschi A, Bacon CM, Borkhardt A, Boztug K, Fischer U, Hauck F, Kuiper RP, Lammens T, Loeffen J, Neven B, Pan-Hammarström Q, Quinti I, Seidel MG, Warnatz K, Wehr C, Lankester AC, Gennery AR.

Front Immunol. 2018 Dec 12;9:2912. doi: 10.3389/fimmu.2018.02912. eCollection 2018. Review.

16.

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Jan;39(1):45-54. doi: 10.1007/s10875-018-0577-9. Epub 2018 Dec 13. Erratum in: J Clin Immunol. 2019 Feb;39(2):225-227.

17.

Herd immunity and primary immune deficiencies.

Farrugia A, Quinti I.

Vaccine. 2019 Jul 9;37(30):3942-3943. doi: 10.1016/j.vaccine.2018.11.059. Epub 2018 Nov 26.

PMID:
30497836
18.

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.

Pulvirenti F, Pecoraro A, Cinetto F, Milito C, Valente M, Santangeli E, Crescenzi L, Rizzo F, Tabolli S, Spadaro G, Agostini C, Quinti I.

Front Immunol. 2018 Nov 5;9:2546. doi: 10.3389/fimmu.2018.02546. eCollection 2018.

19.

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data.

Odnoletkova I, Kindle G, Quinti I, Grimbacher B, Knerr V, Gathmann B, Ehl S, Mahlaoui N, Van Wilder P, Bogaerts K, de Vries E; Plasma Protein Therapeutics Association (PPTA) Taskforce.

Orphanet J Rare Dis. 2018 Nov 12;13(1):201. doi: 10.1186/s13023-018-0941-0.

20.

Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID.

Pulvirenti F, Camilli R, Giufrè M, Milito C, Pimentel de Araujo F, Mancini F, Cardines R, Ciervo A, Pantosti A, Cerquetti M, Quinti I.

J Allergy Clin Immunol. 2018 Dec;142(6):1999-2002.e3. doi: 10.1016/j.jaci.2018.08.014. Epub 2018 Aug 28. No abstract available.

21.

Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?

Ponsford MJ, Klocperk A, Pulvirenti F, Dalm VASH, Milota T, Cinetto F, Chovancova Z, Rial MJ, Sediva A, Litzman J, Agostini C, van Hagen M, Quinti I, Jolles S.

Allergy. 2018 Nov;73(11):2122-2136. doi: 10.1111/all.13578. Epub 2018 Oct 2. Review.

PMID:
30043993
22.

Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders.

Prezzo A, Cavaliere FM, Milito C, Bilotta C, Iacobini M, Quinti I.

Blood Transfus. 2019 Mar;17(2):103-111. doi: 10.2450/2018.0043-18. Epub 2018 Jul 17.

23.

Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42].

Spadaro G, Vultaggio A, Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2018 Apr;57:201. doi: 10.1016/j.intimp.2017.10.014. Epub 2017 Oct 28. No abstract available.

PMID:
29089244
24.

Health-Related Quality of Life and Patients' Empowerment in the Health Care of Primary Immune Deficiencies.

Quinti I, Pulvirenti F.

J Clin Immunol. 2017 Oct;37(7):615-616. doi: 10.1007/s10875-017-0428-0. Epub 2017 Aug 17. No abstract available.

25.

Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.

Jolles S, Sánchez-Ramón S, Quinti I, Soler-Palacín P, Agostini C, Florkin B, Couderc LJ, Brodszki N, Jones A, Longhurst H, Warnatz K, Haerynck F, Matucci A, de Vries E.

Clin Exp Immunol. 2017 Nov;190(2):226-234. doi: 10.1111/cei.13012. Epub 2017 Aug 25.

26.

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

Quinti I, Mitrevski M.

Front Immunol. 2017 Jun 16;8:697. doi: 10.3389/fimmu.2017.00697. eCollection 2017.

27.

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement.

Cavaliere FM, Prezzo A, Bilotta C, Iacobini M, Quinti I.

PLoS One. 2017 Apr 19;12(4):e0175961. doi: 10.1371/journal.pone.0175961. eCollection 2017.

28.

Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.

Spadaro G, Vultaggio A, Alberto Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2017 Mar;44:38-42. doi: 10.1016/j.intimp.2016.12.030. Epub 2017 Jan 7. Erratum in: Int Immunopharmacol. 2018 Apr;57:201.

PMID:
28073042
29.

Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire.

Quinti I, Pulvirenti F, Giannantoni P, Hajjar J, Canter DL, Milito C, Abeni D, Orange JS, Tabolli S.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1169-1179.e4. doi: 10.1016/j.jaip.2016.07.012. Epub 2016 Sep 21.

30.

Reply.

Bonilla FA, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):1019-20. doi: 10.1016/j.jaip.2016.04.029. No abstract available.

31.

Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.

Danieli MG, Pulvirenti F, Rocchi V, Morariu R, Quinti I.

Immunotherapy. 2016 Sep;8(9):995-1002. doi: 10.2217/imt-2016-0035.

PMID:
27485073
32.

Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency.

Prezzo A, Cavaliere FM, Bilotta C, Iacobini M, Quinti I.

Cell Immunol. 2016 Aug-Sep;306-307:25-34. doi: 10.1016/j.cellimm.2016.05.006. Epub 2016 May 28.

PMID:
27264689
33.

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.

Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, Lucas CL, Matthews H, Deau MC, Sharapova S, Curtis J, Reichenbach J, Glastre C, Parry DA, Arumugakani G, McDermott E, Kilic SS, Yamashita M, Moshous D, Lamrini H, Otremba B, Gennery A, Coulter T, Quinti I, Stephan JL, Lougaris V, Brodszki N, Barlogis V, Asano T, Galicier L, Boutboul D, Nonoyama S, Cant A, Imai K, Picard C, Nejentsev S, Molina TJ, Lenardo M, Savic S, Cavazzana M, Fischer A, Durandy A, Kracker S.

J Allergy Clin Immunol. 2016 Jul;138(1):210-218.e9. doi: 10.1016/j.jaci.2016.03.022. Epub 2016 Apr 21.

34.

Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.

Pulvirenti F, Zuntini R, Milito C, Specchia F, Spadaro G, Danieli MG, Pession A, Quinti I, Ferrari S.

J Immunol Res. 2016;2016:8390356. doi: 10.1155/2016/8390356. Epub 2016 Mar 30.

35.

Otologic evaluation of patients with primary antibody deficiency.

Magliulo G, Iannella G, Granata G, Ciofalo A, Pasquariello B, Angeletti D, La Marra F, Quinti I.

Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3537-3546. Epub 2016 Mar 2.

PMID:
26935054
36.

Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies.

Pulvirenti F, Granata G, Girelli G, Quinti I.

Expert Rev Clin Immunol. 2016 Jul;12(7):725-31. doi: 10.1586/1744666X.2016.1151787. Epub 2016 Mar 3. Review.

PMID:
26854522
37.

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):38-59. doi: 10.1016/j.jaip.2015.07.025. Epub 2015 Nov 7. No abstract available.

38.

Editorial: Immunoglobulin Therapy in the 21st Century - the Dark Side of the Moon.

Farrugia A, Visentini M, Quinti I.

Front Immunol. 2015 Aug 26;6:436. doi: 10.3389/fimmu.2015.00436. eCollection 2015. No abstract available.

39.

B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand.

Giardino G, Cirillo E, Gallo V, Esposito T, Fusco F, Conte MI, Quinti I, Ursini MV, Carsetti R, Pignata C.

Clin Immunol. 2015 Dec;161(2):131-5. doi: 10.1016/j.clim.2015.08.008. Epub 2015 Aug 22.

PMID:
26307434
40.

Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy.

Moschese V, Cavaliere FM, Graziani S, Bilotta C, Milito C, Chini L, Quinti I.

J Allergy Clin Immunol. 2016 Feb;137(2):617-9. doi: 10.1016/j.jaci.2015.06.014. Epub 2015 Jul 30. No abstract available.

PMID:
26233927
41.

Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies.

Cavaliere FM, Prezzo A, Conti V, Bilotta C, Pulvirenti F, Iacobini M, Quinti I.

Int Immunopharmacol. 2015 Sep;28(1):596-603. doi: 10.1016/j.intimp.2015.07.017. Epub 2015 Jul 28.

PMID:
26232049
42.

Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies.

Milito C, Pulvirenti F, Serra G, Valente M, Pesce AM, Granata G, Catalano C, Fraioli F, Quinti I.

J Clin Immunol. 2015 Jul;35(5):491-500. doi: 10.1007/s10875-015-0172-2. Epub 2015 Jun 12.

43.

Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia.

Leuzzi V, Micheli R, D'Agnano D, Molinaro A, Venturi T, Plebani A, Soresina A, Marini M, Ferremi Leali P, Quinti I, Pietrogrande MC, Finocchi A, Fazzi E, Chessa L, Magnani M.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e98. doi: 10.1212/NXI.0000000000000098. eCollection 2015 Jun.

44.

On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Späth PJ, Granata G, La Marra F, Kuijpers TW, Quinti I.

Front Immunol. 2015 Feb 5;6:11. doi: 10.3389/fimmu.2015.00011. eCollection 2015. Review.

45.

A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.

Clemente N, Boggio E, Gigliotti CL, Orilieri E, Cappellano G, Toth E, Valletti PA, Santoro C, Quinti I, Pignata C, Notarangelo LD, Dianzani C, Dianzani I, Ramenghi U, Dianzani U, Chiocchetti A.

Genes Immun. 2015 Mar;16(2):151-61. doi: 10.1038/gene.2014.74. Epub 2015 Jan 8.

46.

Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy.

Farrugia A, Quinti I.

Front Immunol. 2014 Dec 23;5:665. doi: 10.3389/fimmu.2014.00665. eCollection 2014. Review.

47.

Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Kerr J, Quinti I, Eibl M, Chapel H, Späth PJ, Sewell WA, Salama A, van Schaik IN, Kuijpers TW, Peter HH.

Front Immunol. 2014 Dec 12;5:629. doi: 10.3389/fimmu.2014.00629. eCollection 2014. Review.

48.

Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment.

Quinti I, Pulvirenti F, Milito C, Granata G, Giovannetti G, La Marra F, Pesce AM, Farrugia A, Coluzzi S, Girelli G.

Transfusion. 2015 May;55(5):1067-74. doi: 10.1111/trf.12939. Epub 2014 Dec 22.

PMID:
25532440
49.

Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies.

Tabolli S, Giannantoni P, Pulvirenti F, La Marra F, Granata G, Milito C, Quinti I.

Front Immunol. 2014 Nov 26;5:605. doi: 10.3389/fimmu.2014.00605. eCollection 2014.

50.

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.

Mitrevski M, Marrapodi R, Camponeschi A, Lazzeri C, Todi L, Quinti I, Fiorilli M, Visentini M.

Immunol Res. 2014 Dec;60(2-3):330-8. doi: 10.1007/s12026-014-8599-8.

PMID:
25407649

Supplemental Content

Loading ...
Support Center